arrow
M

Marco Lucioni

irccs fondazione san matteo
H指数:34
被引数:5,025

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical features and survival in primary intestinal lymphomas: A multicentre study

原发性肠道淋巴瘤的临床特征和生存: 一项多中心研究

2026-01-130
OAAI
Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort

临床表现、治疗及28例Castleman病患者结局:一项意大利队列的回顾性分析

2025-12-010
OAAI
Persistence of Monotypic Plasma Cells after Chemoimmunotherapy in Patients with Waldenström Macroglobulinemia: A Matter of Time?

在化疗免疫疗法后,华氏巨球蛋白血症患者单型性浆细胞的持续性:真的是时间问题吗?

BLOOD
IF23.1
2024-11-050
PRE
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypes
2024-07-180
OAAI
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature
2023-02-219
OAAI
Tissue fluidification promotes a cGAS-STING cytosolic DNA response in invasive breast cancer (dec, 10.1038/s43588-01431-x, 2022)
2023-01-261
OAAI
Tissue fluidification promotes a cGAS-STING cytosolic DNA response in invasive breast cancer
2022-12-2934
OAAI
Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience
2022-12-062
OAAI
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study
2022-11-268
OAAI
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center

前哨淋巴结活检阳性的乳腺癌患者腋窝的管理: 欧洲乳腺中心的循证更新

EJSO
IF2.9
2020-01-0133
PREAI
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit A position paper from the Italian Group of Haematopathology (GIE)
2019-08-0612
OAAI